[Skip to content]

European Parkinson's Disease Association
Search our Site


  • Parkinson Italia White Book on Parkinson's diseaseAt the 2nd National Meeting of Parkinson's Italia, people with Parkinson's from all over Italy met up in Vasto, Abruzzo, the national group together with the local associations have instigated a new project with the aim of establishing a "complete" picture of the issues connected to Parkinson's disease in Italy. 23 July 2015
  • Parkinson Bizkaia – Asparbi Parkinson Bizkaia Association (ASPARBI) Campaign - 'I join the movement against Parkinson'Parkinson Bizkaia Association (ASPARBI) recently launched the campaign 'I join the movement against Parkinson' with the aim of promoting an easily recognisable gesture which identifies Parkinson's disease at an international level. 22 July 2015
  • Biotie Therapies Biotie announces start of tozadenant Phase 3 Study in Parkinson's diseaseBiotie announces the start of the Phase 3 clinical study of tozadenant, an investigational adenosine A2a receptor antagonist, in patients with Parkinson's disease (PD) experiencing levodopa related end-of-dose "wearing-off". 21 July 2015
  • Washington University in St. Louis Device delivers drugs to brain via remote controlA team of researchers has developed a wireless device the width of a human hair that can be implanted in the brain and activated by remote control to deliver drugs. 16 July 2015
  • MHRA logo (new) BIA and MHRA publish report following joint conference Pathway of Innovation from Research to PatientsThe UK BioIndustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA) today publish a report following their fifth joint annual conference, Pathway of Innovation from Research to Patients, held on 11 June at the Wellcome Trust. 16 July 2015
  • MHRA logo (new) Digital evolution for ground-breaking Yellow Card SchemeFifty years on from its inception, the Yellow Card Scheme is moving into the digital age through a free-access mobile app that was launched today (14 July) by Life Sciences Minister, Mr George Freeman MP. 14 July 2015
  • AbbVie NHS England approves routine commissioning for Parkinson's treatment DuodopaAbbVie welcomes the decision by NHS England to routinely commission Duodopa (Levodopa-carbidopa intestinal gel - LCIG) for the first time. 03 July 2015
  • Parkinson's UK Campaign success: NHS England to fund DuodopaThe NHS in England has announced they will fund Duodopa, a life-changing drug for people with advanced Parkinson's. This means that should a specialist Parkinson's clinician prescribe Duodopa, a person with Parkinson's will be able to receive it without delay. 02 July 2015
  • Herantis Pharma Herantis Pharma granted almost 3 million Euro government loan for Parkinson studyTekes, the Finnish Funding Agency for Innovation, has granted a 2,903,000 EUR R&D loan to Herantis Pharma Plc to support its clinical study of CDNF for the treatment of Parkinson's disease. The loan was granted conditionally subject to obtaining regulatory approval for the clinical study. 30 June 2015
  • Medpage Today Diabetes drug found useless for Parkinson'sThe diabetes drug pioglitazone (Actos) isn't likely to slow the progression of early Parkinson's disease, researchers reported. A futility study showed in several analyses that both doses of the drug that were tested (15 mg and 45 mg) were futile at slowing disease progression, Tanya Simuni, MD, of Northwestern University, and colleagues reported online in the Lancet Neurology. 28 June 2015
Page: [1] [2] [3]